Mabpharm Limited (HKG:2181)
0.4350
+0.0050 (1.16%)
Aug 27, 2026, 1:42 PM HKT
-43.51% (1Y)
| Market Cap | 1.79B -44.2% |
| Revenue (ttm) | 718.98M +150.2% |
| Net Income | 63.58M |
| EPS | 0.01 |
| Shares Out | 4.12B |
| PE Ratio | 39.09 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 210,000 |
| Open | 0.4100 |
| Previous Close | 0.4300 |
| Day's Range | 0.4000 - 0.4350 |
| 52-Week Range | 0.3100 - 0.8700 |
| Beta | 0.60 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 28, 2026 |